This exchange-traded fund tracks the NYSE Arca Biotechnology Index, providing investors exposure to U.S.-listed biotechnology companies. FBT is widely followed as a liquid, diversified play on biotech innovation and M&A activity in the sector.
3 members of Congress have disclosed 5 trades in First Trust NYSE Arca Biotechnology Index Fund (FBT), a Healthcare company. The buy/sell breakdown shows 4 purchases versus 1 sale, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2016-02-02 | MICHAEL K. SIMPSON | sell | $15K – $50K |
| 2015-09-21 | MICHAEL K. SIMPSON | buy | $1K – $15K |
| 2015-01-08 | MICHAEL K. SIMPSON | buy | $1K – $15K |
| 2010-01-10 | Tim Walberg | buy | $1K – $15K |
| 2009-11-03 | CHARLES A. WILSON | buy | $1K – $15K |